Login Register Cart 0
Generic placeholder image

Current Drug Therapy

Editor-in-Chief

ISSN (Print): 1574-8855
ISSN (Online): 2212-3903

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Hepatoprotective Potential of Phytoconstituents and Vitamins against Antitubercular Drugs Induced Hepatotoxicity in Albino Rats

Author(s): Babul Kumari*, Tirath Kumar, Dhananjay Kumar and Aninda Sen

Volume 18, Issue 3, 2023

Published on: 02 February, 2023

Page: [237 - 246] Pages: 10

DOI: 10.2174/1574885518666221216100311

Price: $65

Abstract

Background: This study aims to develop a new hepatoprotective drug from common plants and vitamins that are potent, nontoxic, and cost-effective. The literature search found that Curcuma longa , Zingiber officinale, Terminalia, chebula, and Vitamin A (Vitamin C + Vitamin E) provide hepatoprotective action against drugs-induced hepatotoxicity. A major side effect of antitubercular drugs (ATD) is liver toxicity, which reduces their effectiveness.

Aim: In this study, Vitamins and Phytoconstituents (Combined extract) were evaluated for their potential hepatoprotective effects against hepatotoxicity induced by antitubercular drugs in Wistar albino rats of either sex.

Materials and Methods: In the study, ethanolic extract of rhizomes of Curcuma longa and Zingiber officinale , fruits of Terminalia chebula , and vitamins C and E were used. As a standard drug, silymarin was also used. For 30 days, albino rats received 7.5 mg/kg isoniazid, 10 mg/kg rifampicin, and 35 mg/kg pyrazinamide orally as a suspension in distilled water.

Result: A combined extract plus vitamins (500mg/kg) treatment significantly reduced the hepatic toxicity caused by antitubercular drugs (P<0.05-P<0.001). A combination of extracts + vitamins (500mg/kg) eliminates hepatotoxicity, and the results are close to those of Silymarin, a standard drug.

Conclusion: As a result of this study, extracts+vitamins provide protection against liver injury attributed to their hepatoprotective activity, which supports their traditional use.

Keywords: Curcuma longa extract, Zingiber officinale extract, Terminalia chebula extract, vitamins, isoniazid, rifampin, pyrazinamide, liver enzymes.

« Previous Next »
Graphical Abstract

[1]
Ostapowicz G, Fontana RJ, Schiødt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137(12): 947-54.
[http://dx.doi.org/10.7326/0003-4819-137-12-200212170-00007] [PMID: 12484709]
[2]
Aithal PG, Day CP. The natural history of histologically proved drug induced liver disease. Gut 1999; 44(5): 731-5.
[http://dx.doi.org/10.1136/gut.44.5.731] [PMID: 10205214]
[3]
Bhawna S, Kumar SU. Hepatoprotective activity of some indigenous plants. Int J Pharm Tech Res 2009; 4: 1330-4.
[4]
Haque MdR, Ahmad MdA, Ashraf K. Arq ajwain protects nonalcoholic fatty liver disease on high-fat diet-induced obese rat. Trends Phytochem Res 2021; 5(4): 209-21.
[5]
Kokate CK, Purohit AP, Ghokhale SB. Pharmacognosy Nirali Prakashan. Pune, India 2017; pp. 137-9.
[6]
Gupta PC. Biological and pharmacological properties of Terminalia chebula Retz. (Haritaki) an overview. Int J Pharm Tech Res 2012; 4(3): 62-8.
[7]
Mohammed A. PharmacognosyVolume-1. New Delhi: CBS Publishers and Distributors Pvt. Ltd 2008; pp. 528-30.
[8]
Kumar G, Kathie L, Rao KVB. A review on pharmacological and phytochemical properties of Zingiber officinale Roscoe (Zingiberaceae). J Pharm Res 2011; 4(9): 2963-6.
[9]
Kumari B, Kumar T. Hepatoprotective effect of Zingiber officinale roscoe against anti-tubercular drug-induced liver toxicity in albino rats. J Glob Pharma Technol 2019; 11(11): 1-6.
[10]
Ravindran PN, Babu KN, Sivaraman K. Turmeric: the genus Curcuma. Boca Raton: CRC Press 2007; pp. 277-80.
[11]
Devaki SJ, Raveendran RL. Vitamin C: Sources. Functions, Sensing, and Analysis 2017; pp. 1-18.
[12]
Rizvi S, Raza ST, Ahmed F, Ahmad A, Abbas S, Mahdi F. The role of vitamin e in human health and some diseases. Sultan Qaboos Univ Med J 2014; 14(2): e157-65.
[PMID: 24790736]
[13]
Hussain T, Gupta RK, Sweety K, et al. Evaluation of antihepatotoxic potential of Solanum xanthocarpum fruit extract against antitubercular drugs induced hepatopathy in experimental rodents. Asian Pac J Trop Biomed 2012; 2(6): 454-60.
[http://dx.doi.org/10.1016/S2221-1691(12)60075-6] [PMID: 23569949]
[14]
Pari L, Kumar NA. Hepatoprotective activity of Moringa oleifera on antitubercular drug-induced liver damage in rats. J Med Food 2002; 5(3): 171-7.
[http://dx.doi.org/10.1089/10966200260398206] [PMID: 12495589]
[15]
Tasduq SA, Kaisar P, Gupta DK, et al. Protective effect of a 50% hydroalcoholic fruit extract of Emblica officinalis against anti-tuberculosis drugs induced liver toxicity. Phytother Res 2005; 19(3): 193-7.
[http://dx.doi.org/10.1002/ptr.1631] [PMID: 15934014]
[16]
IFCC Methods. For the measurement of catalytic concentrations of enzymes. J Clinic Chem Clinic Biochem 1986; 24: 481-97.
[17]
Wilkinson JH, Boutwell JH, Winsten S. Evaluation of a new system for the kinetic measurement of serum alkaline phosphatase. Clin Chem 1969; 15(6): 487-95.
[http://dx.doi.org/10.1093/clinchem/15.6.487] [PMID: 5786804]
[18]
Pearlman FC, Lee RTY. Detection and measurement of total bilirubin in serum, with use of surfactants as solubilizing agents. Clin Chem 1974; 20(4): 447-53.
[http://dx.doi.org/10.1093/clinchem/20.4.447] [PMID: 4818198]
[19]
Goodwin JF. Automation in Anal. Chem Technicon syumposia 1965; 315-20.
[20]
Doumas BT, Arends RI, Pinto RO. in standard methods of Clinical Chemistry. Academic Press Chicago 1972; 7: 175-89.
[21]
Devasagayam TPA, Tarachand U. Decreased lipid peroxidation in the rat kidney during gestation. Biochem Biophys Res Commun 1987; 145(1): 134-8.
[http://dx.doi.org/10.1016/0006-291X(87)91297-6] [PMID: 3593335]
[22]
Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47(3): 469-74.
[http://dx.doi.org/10.1111/j.1432-1033.1974.tb03714.x] [PMID: 4215654]
[23]
Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972; 47(2): 389-94.
[http://dx.doi.org/10.1016/0003-2697(72)90132-7] [PMID: 4556490]
[24]
Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. J Biol Chem 1974; 249(22): 7130-9.
[http://dx.doi.org/10.1016/S0021-9258(19)42083-8] [PMID: 4436300]
[25]
Sharma SK, Balamurugan A, Saha PK, Pandey RM, Mehra NK. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med 2002; 166(7): 916-9.
[http://dx.doi.org/10.1164/rccm.2108091] [PMID: 12359646]
[26]
Padmapriyadarsini C, Chandrabose J, Victor L, Hanna LE, Arunkumar N, Swaminathan S. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function. J Postgrad Med 2006; 52(2): 92-6.
[PMID: 16679670]
[27]
Ramappa V, Aithal GP. Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management. J Clin Exp Hepatol 2013; 3(1): 37-49.
[http://dx.doi.org/10.1016/j.jceh.2012.12.001] [PMID: 25755470]
[28]
Stricker BH. Drug-induced hepatic injuryDrug-induced Disorders. Amsterdam: Elviser 1992.
[29]
Shih TY, Pai CY, Yang P, Chang WL, Wang NC, Hu OYP. A novel mechanism underlies the hepatotoxicity of pyrazinamide. Antimicrob Agents Chemother 2013; 57(4): 1685-90.
[http://dx.doi.org/10.1128/AAC.01866-12] [PMID: 23357778]
[30]
Attri S, Rana SV, Vaiphei K, Sodhi CP, Katyal R, Goel RC. Isoniazid- and rifampicin-induced oxidative hepatic injury–protection by N-acetylcysteine. Human Experiment Toxicol 2000; 19(9): 517-24.
[31]
Funde S, Jaju J, Dharmadhikari S, Pawar G. Effect of Lagenaria siceraria fruit extract (Bottle gourd) on hepatotoxicity induced by antitubercular drugs in albino rats. Int J Basic Clin Pharmacol 2013; 2(6): 728-34.
[http://dx.doi.org/10.5455/2319-2003.ijbcp20131211]
[32]
Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992; 119(6): 598-620.
[PMID: 1593209]
[33]
Sen S, Chakraborty R, Sridhar C, Reddy YSR, De B. Free radicals, antioxidants, disease, and phytomedicines: current status and future prospect. Int J Pharm Sci Rev Res 2010; 3(1): 91-100.
[34]
Mujahid M, Hussain T, Siddiqui HH, Hussain A. Evaluation of hepatoprotective potential of Erythrina indica leaves against antitubercular drugs induced hepatotoxicity in experimental rats. J Ayurveda Integr Med 2017; 8(1): 7-12.
[http://dx.doi.org/10.1016/j.jaim.2016.10.005] [PMID: 27916487]
[35]
Kale BP, Kothekar MA, Tayade HP, Jaju JB. Effect of aqueous extract of Azadirachta indica leaves on hepatotoxicity induced by antitubercular drugs in rats. Indian J Pharmacol 2003; 35: 177-80.
[36]
Tasduq SA, Singh K, Satti NK, Gupta DK, Suri KA, Johri RK. Terminalia chebula (fruit) prevents liver toxicity caused by sub-chronic administration of rifampicin, isoniazid and pyrazinamide in combination. Hum Exp Toxicol 2006; 25(3): 111-8.
[http://dx.doi.org/10.1191/0960327106ht601oa] [PMID: 16634329]
[37]
Adhvaryu MR, Reddy N, Parabia MH. Effects of four Indian medicinal herbs on Isoniazid-, Rifampicin- and Pyrazinamide-induced hepatic injury and immunosuppression in guinea pigs. World J Gastroenterol 2007; 13(23): 3199-205.
[http://dx.doi.org/10.3748/wjg.v13.i23.3199] [PMID: 17589898]
[38]
Kumari B, Kumar T, Kaur V. Hepatoprotective effect of ethanolic extract of Curcuma longa Linn on antitubercular drugs induced hepatotoxicity in albino rats. Int Res J Pharm 2018; 9(10): 106-10.
[http://dx.doi.org/10.7897/2230-8407.0910235]
[39]
Sminorff N, Wheeler GL. Ascorbic acid in plants biosynthesis and function. Crit Rev Biochem Mol Biol 2000; 19: 267-90.
[40]
Bradford A, Atkinson J, Fuller N, Rand RP. The effect of vitamin E on the structure of membrane lipid assemblies. J Lipid Res 2003; 44(10): 1940-5.
[http://dx.doi.org/10.1194/jlr.M300146-JLR200] [PMID: 12867540]
[41]
Hismiogullar ISE, Hismiogullar IAA, Sunay FB, et al. The protective effect of curcumin on carbon tetrachloride induced liver damage. Rev Med Vet 2014; 165: 7-8, 194-200.
[42]
Akinloye OA, Somade OT, Akindele AS, Adelabu KB, Elijah FT, Adewumi OJ. Anticlastogenic and hepatoprotective properties of ginger (Zingiber Officinale) extract against nitrobenzene-induced toxicity in rats. Rom J Biochem 2014; 51: 3-15.
[43]
Adikwu Elias, Onyedenyifa OJ, Samue NK. Effects of Vitamins C and E on tenofovir and nevirapine-induced hepatorenal toxicity in male albino rats. Int J Biomed Res 2016; 7(4): 211-8.

Rights & Permissions Print Cite
Article Metrics
18
2
© 2024 Bentham Science Publishers | Privacy Policy